7TM Pharma

Denmark
Kongens Lyngby, Capital Region, Denmark
+45 45-3925-7777 ★

Company profile

7TM Pharma company profile

7TM Pharma is a biotech company that discovers and develops drugs with a primary therapeutic focus on diabetes, gastrointestinal, metabolic, asthma, and vascular diseases. The company offers seven transmembrane-spanning receptors, including TM38837, a small molecule CB1 receptor antagonist; TM30339, a NPY Y4 selective agonist that is used within gastrointestinal disorders, and short bowel syndrome; and CRTH2 antagonist, an oral drug for inflammatory or respiratory diseases. 7TM Pharma was founded in 2000 and is based in Lyngby, Hovedstaden.

Business identity

Phone number
+45 45-3925-7777
Operating status
Closed
Company type
For Profit
Employee range
00011-00050 employees
Founded
2000-01-01

Headquarters

Headquarters
Kongens Lyngby, Capital Region, Denmark
Postal code
2970
Country code
DK
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
6
Total equity funding
$82.7M
Last funding
Series Unknown / $15M / 2009-01-15
Last equity funding
Series Unknown / $15M
Investors
9
Lead investors
4
Founders
2
Closed on
2023-06-26

Founders and investors

Founders

Christian E. EllingMette Kirstine Agger

Lead investors

Index VenturesJohnson & Johnson Development CorporationLD PensionsSR One

Investors

Alta PartnersIndex VenturesJohnson & Johnson Development CorporationNovo HoldingsSR One

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.